The Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) based at the Pirbright Institute will support the development and deployment of vaccine technologies to combat neglected and emerging diseases of livestock, including
zoonotic diseases that represent a threat to public health. To enable this, a new GMP facility, scheduled for completion in early 2026, will need to be equipment with appropriate equipment.

You must be logged in to view the rest of this content, click here to login

Don't have an account, click to sign up for our 14-day free trial.